HOXA13 and hepatocellular carcinoma: High expression of both HOTTIP and HOXA13 was correlated with metastasis formation and poor patient survival in HCC, suggesting that HOTTIP/HOXA13 expression may be a possible marker for predicting clinical outcomes in HCC patients (47).